DrugPatentWatch Database Preview
Profile for United States of America Patent: 2002028770
US Patent Family Members and Approved Drugs for United States of America Patent: 2002028770
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | May 6, 2021 | Theravance Biopharma | VIBATIV | telavancin hydrochloride |
➤ Sign Up | May 1, 2021 | Theravance Biopharma | VIBATIV | telavancin hydrochloride |
➤ Sign Up | May 1, 2021 | Theravance Biopharma | VIBATIV | telavancin hydrochloride |
➤ Sign Up | May 1, 2021 | Theravance Biopharma | VIBATIV | telavancin hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |